Application note: Combining automated patch clamp, impedance and EFP of hiPSC-Cardiomyocytes

Application note: Activation and Inhibition of human ASIC3 Channels on Nanion’s SyncroPatch 384PE

Application note: High Throughput Pharmacology of CaV3.2 Channels on Nanion’s SyncroPatch 384PE

Application note: High Throughput Pharmacology of hERG Channels on Nanion’s SyncroPatch 384PE

Application note: High Throughput Pharmacology of NaV1.5 Channels on Nanion's SyncroPatch 384PE

Application note: Characterization of hNaV1.7 on Nanion's SyncroPatch 384PE

Application note: High Throughput Activation and Block of hTRPA1 on Nanion’s SyncroPatch 384PE

Application Note: Activation and Inhibition of human NMDA Channels on Nanion`s SyncroPatch 384PE

Application note: Simultaneous Assessment of CiPA Stipulated Ion Channels on the SyncroPatch 384PE

Application Note: Internal perfusion of Ca2+ to activate hTRPC5 on Nanion's SyncroPatch 384PE

Application note: High Throughput Screening of Cardiac Ion Channels

Application note: Characterization of CaV1.3 on Nanion's SyncroPatch 96

Application note: Characterization of hGABAA α1β3γ2 on Nanion's SyncroPatch 96

Application note: Characterization of hGABAA α5β3γ2 on Nanion's SyncroPatch 96

Application note: Pharmacology on rNaV1.7 performed on Nanion‘s SyncroPatch 96

Application note: Characterization of rNaV1.8 (ND7-23) on Nanion's SyncroPatch 96

Application note: Internal perfusion of Ca2+ to activate TMEM16A/ANO1 on the SyncroPatch 384PE

Application note: Different modes of activation of CFTR recorded on Nanion’s SyncroPatch 384PE

Application note: High Throughput Pharmacology of CaV1.2 Channels on Nanion’s SyncroPatch 384PE

Application note: Stability and Pharmacology of CaV1.2 Channels on Nanion’s SyncroPatch 384PE